US Supreme Court backs FCC in clash with wireless carriers over fines - Reuters
Article excerpt
The Supreme Court sided with the FCC in a dispute with wireless carriers over the agency's authority to levy fines. The case centered on whether the FCC could penalize carriers beyond a specific monetary threshold without explicit congressional approval. In backing the FCC, the justices upheld the regulatory agency's power to impose significant financial penalties on telecommunications companies that violate communications law. The decision strengthens the FCC's enforcement toolkit as it pursues violations ranging from robocalls to network outages.
The Supreme Court unanimously ruled that Hikma Pharmaceuticals did not infringe patents held by Amarin in a decision that makes generic drugmakers less vulnerable to lawsuits over so-called skinny labels.
The ruling overturned a lower court decision that sided with Amarin. Generic drugmakers had argued that, if the Supreme Court also ruled in favor of Amarin, they would be discouraged from making and selling lower-cost versions of brand-name medicines, which would maintain higher prices for prescription drugs.
At issue is skinny labeling, which refers to moves by generic companies that seek regulatory approval to market a medicine for a specific use, but not other patented uses for which a brand-name drug is prescribed. For instance, a generic drug could be marketed to treat one type of heart problem but not another. In doing so, the generic company seeks to avoid lawsuits claiming patent infringement.
Continue to STAT+ to read the full story…